BBR Partners LLC Makes New Investment in Viemed Healthcare, Inc. (NASDAQ:VMD)

BBR Partners LLC acquired a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 15,000 shares of the company’s stock, valued at approximately $110,000.

Several other large investors also recently made changes to their positions in the stock. Evernest Financial Advisors LLC bought a new stake in Viemed Healthcare in the second quarter valued at approximately $66,000. Perkins Coie Trust Co bought a new position in Viemed Healthcare in the 3rd quarter valued at about $73,000. Victory Capital Management Inc. lifted its position in Viemed Healthcare by 21.1% during the second quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock worth $84,000 after acquiring an additional 2,226 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of Viemed Healthcare during the third quarter worth approximately $89,000. Finally, Price T Rowe Associates Inc. MD acquired a new position in shares of Viemed Healthcare in the first quarter valued at approximately $97,000. Institutional investors and hedge funds own 74.24% of the company’s stock.

Insider Transactions at Viemed Healthcare

In other Viemed Healthcare news, Director Randy E. Dobbs sold 36,261 shares of the company’s stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the completion of the sale, the director now directly owns 107,706 shares in the company, valued at $999,511.68. This represents a 25.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Nitin Kaushal sold 5,995 shares of Viemed Healthcare stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $8.58, for a total value of $51,437.10. Following the completion of the transaction, the director now owns 126,843 shares in the company, valued at approximately $1,088,312.94. The trade was a 4.51 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 72,256 shares of company stock valued at $674,739. 20.00% of the stock is owned by corporate insiders.

Viemed Healthcare Stock Performance

NASDAQ:VMD opened at $8.56 on Friday. The stock has a 50 day simple moving average of $8.56 and a 200 day simple moving average of $7.59. The stock has a market cap of $333.33 million, a P/E ratio of 31.70 and a beta of 1.43. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $10.44. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The business had revenue of $58.00 million during the quarter.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.